Ramutton et al., 2014 - Google Patents
γδ T cells as a potential tool in colon cancer immunotherapyRamutton et al., 2014
View PDF- Document ID
- 2406010635810481543
- Author
- Ramutton T
- Buccheri S
- Dieli F
- Todaro M
- Stassi G
- Meraviglia S
- Publication year
- Publication venue
- Immunotherapy
External Links
Snippet
γδ T cells are capable of recognizing tumor cells and exert potent cellular cytotoxicity against a large range of tumors, including colon cancer. However, tumors utilize numerous strategies to escape recognition or killing by patrolling γδ T cells, such a downregulation of …
- 210000001744 T-Lymphocytes 0 title abstract description 135
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leclerc et al. | Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1 | |
| Whiteside | FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity | |
| Ramutton et al. | γδ T cells as a potential tool in colon cancer immunotherapy | |
| Menon et al. | Advances in cancer immunotherapy in solid tumors | |
| Angell et al. | MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro | |
| Cheng et al. | Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy | |
| Scaltriti et al. | Molecular pathways: AXL, a membrane receptor mediator of resistance to therapy | |
| Zhang et al. | The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice | |
| Jiang et al. | T-cell exhaustion in the tumor microenvironment | |
| Zhou et al. | Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras | |
| Hong et al. | Successful treatment of melanoma brain metastases with adoptive cell therapy | |
| Ascierto et al. | Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types | |
| Zhu et al. | Evasion of innate immunity contributes to small cell lung cancer progression and metastasis | |
| Migita et al. | Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma | |
| Kornacker et al. | Cytokine‐induced killer cells against autologous CLL: Direct cytotoxic effects and induction of immune accessory molecules by interferon‐γ | |
| Huang et al. | Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG 2 | |
| Jäkel et al. | An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells | |
| Baragano Raneros et al. | Acute myeloid leukemia and NK cells: two warriors confront each other | |
| Mayor et al. | Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies | |
| Chaudhary et al. | Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer | |
| Moretti et al. | THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside | |
| Filimon et al. | Interleukin-8 in melanoma pathogenesis, prognosis and therapy—an integrated view into other neoplasms and chemokine networks | |
| Caruana et al. | T lymphocytes against solid malignancies: winning ways to defeat tumours | |
| Michelakos et al. | B7-H3 targeted antibody-based immunotherapy of malignant diseases | |
| Ma et al. | PDGF-D− PDGFRβ signaling enhances IL-15–mediated human natural killer cell survival |